Trial Details
COMPLETEDBasic Information
| Clinical ID | c1520 |
|---|---|
| Identifier | NCT06829225 |
| Trial Title | Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Tulisokibart|DRUG: Placebo |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2024-06-13 |
|---|---|
| Primary Completion Date | 2024-11-11 |
| Completion Date | 2024-11-11 |